Market revenue in 2023 | USD 44.7 million |
Market revenue in 2030 | USD 59.9 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 17.9% in 2023. Horizon Databook has segmented the Russia point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
Rising incidence of diabetes in Russia and challenges associated with diabetes management, such as improper data collection, lack of proper treatment solutions, and difficult access to educational initiatives, have led to an increase in investments in Russia glucose POC testing market.
Other challenges include insufficient supplies and lesser availability of strips. According to Diabetes.co.uk, there is high incidence of foot complications and amputations due to diabetes in the country.
According to International Diabetes Federation, there were more than 8.2 million people suffering from diabetes in Russia in 2019. However, increasing investments by large companies and their collaborations with Russian Federation are among factors expected to lead to effective management of diabetes.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Russia point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account